Deka Bank Deutsche Girozentrale Bei Gene, Ltd. Transaction History

Deka Bank Deutsche Girozentrale

$53.9 Billion
Q3 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 13,600 shares of BGNE stock, worth $2.61 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

13,600

Previous 13,600 -0.0%

Holding current value

$2.61 Million

Previous $1.97 Million 61.94%

% of portfolio

0.01%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	SELL	$158.67 - $201.58 $2.54 Million - $3.23 Million	-16,000 Reduced 54.05%	13,600 $2.43 Million
Q3 2023 Nov 13, 2023	BUY	$179.87 - $225.13 $2.45 Million - $3.06 Million	13,600 Added 85.0%	29,600 $5.23 Million
Q2 2023 Jul 25, 2023	SELL	$178.3 - $266.78 $4.46 Million - $6.67 Million	-25,000 Reduced 60.98%	16,000 $2.85 Million
Q1 2023 Apr 24, 2023	BUY	$215.53 - $274.5 $1.08 Million - $1.37 Million	5,000 Added 13.89%	41,000 $8.87 Million
Q4 2022 Feb 01, 2023	SELL	$125.51 - $229.3 $299,215 - $546,651	-2,384 Reduced 6.21%	36,000 $7.91 Million
Q3 2022 Nov 02, 2022	BUY	$131.8 - $202.24 $510,066 - $782,668	3,870 Added 11.21%	38,384 $5.11 Million
Q2 2022 Aug 03, 2022	BUY	$121.11 - $216.05 $391,790 - $698,921	3,235 Added 10.34%	34,514 $5.45 Million
Q1 2022 Apr 28, 2022	SELL	$146.52 - $269.56 $117,802 - $216,726	-804 Reduced 2.51%	31,279 $12.7 Million
Q4 2021 Feb 02, 2022	BUY	$248.56 - $389.34 $1.5 Million - $2.35 Million	6,029 Added 23.14%	32,083 $8.23 Million
Q3 2021 Oct 22, 2021	SELL	$249.6 - $403.14 $43,430 - $70,146	-174 Reduced 0.66%	26,054 $9.24 Million
Q2 2021 Aug 05, 2021	BUY	$292.75 - $367.01 $95,436 - $119,645	326 Added 1.26%	26,228 $9.21 Million
Q1 2021 Apr 28, 2021	SELL	$260.64 - $382.12 $338,050 - $495,609	-1,297 Reduced 4.77%	25,902 $8.52 Million
Q4 2020 Mar 12, 2021	SELL	$221.31 - $316.61 $112,204 - $160,521	-507 Reduced 1.83%	27,199 $6.76 Million
Q3 2020 Oct 29, 2020	BUY	$189.18 - $286.44 $2.85 Million - $4.31 Million	15,053 Added 118.97%	27,706 $7.67 Million
Q2 2020 Aug 04, 2020	SELL	$123.9 - $195.41 $732,001 - $1.15 Million	-5,908 Reduced 31.83%	12,653 $2.35 Million
Q1 2020 May 14, 2020	BUY	$121.84 - $173.19 $1.39 Million - $1.97 Million	11,381 Added 158.51%	18,561 $2.29 Million
Q4 2019 Feb 04, 2020	BUY	$115.78 - $208.34 $831,300 - $1.5 Million	7,180 New	7,180 $1.18 Million
Q3 2019 Nov 14, 2019	SELL	$120.61 - $148.29 $3.85 Million - $4.74 Million	-31,949 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$113.99 - $146.86 $1.82 Million - $2.35 Million	16,004 Added 100.37%	31,949 $4.02 Million
Q1 2019 May 10, 2019	SELL	$122.82 - $151.83 $200,810 - $248,242	-1,635 Reduced 9.3%	15,945 $2.83 Million
Q4 2018 Feb 12, 2019	BUY	$107.01 - $175.15 $174,961 - $286,370	1,635 Added 10.25%	17,580 $2.42 Million
Q3 2018 Nov 09, 2018	SELL	$152.62 - $189.66 $51,890 - $64,484	-340 Reduced 2.09%	15,945 $0
Q2 2018 Aug 14, 2018	SELL	$152.5 - $216.77 $152,500 - $216,770	-1,000 Reduced 5.79%	16,285 $2.52 Million
Q1 2018 May 03, 2018	BUY	$97.41 - $177.22 $1.68 Million - $3.06 Million	17,285 New	17,285 $2.84 Million

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $19.9B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Account

Deka Bank Deutsche Girozentrale Bei Gene, Ltd. Transaction History